Data from the International Spectrum Registry has found that a micro-invasive glaucoma device lowers pressure in patients with primary open-angle glaucoma.
Patients with severe cases of ocular surface disease can be some of the most challenging in ophthalmology, and cannot be treated with a cookbook approach.
